White Papers

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
How Specialty Pharmacy Can Support Value-Based Care and Population Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Support Value-Based Care and Population Health
This white paper discusses how expanding integrated health system specialty pharmacy can be an impactful tool that health systems can leverage to improve their performance under value-based care contracts.
How Specialty Pharmacy Can Address and Impact Social Determinants of Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Address and Impact Social Determinants of Health
Social determinants of health can become barriers to patients receiving adequate health care and are drivers of most health outcomes.
Advancements in Rare Disease Treatment and Management 204 115 Shields Health Solutions

Advancements in Rare Disease Treatment and Management

This white paper discusses how health system-owned specialty pharmacies leveraging Shields’ integrated care model, data aggregation and acceleration solutions can overcome challenges and barriers to care for specialty patients with…

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers 204 115 Shields Health Solutions

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers

This white paper discusses how a specialty pharmacy acceleration company allows drug manufacturers to access the expertise of health systems and their specialty pharmacies through a single point of contact.…

Addressing Total Cost of Care Across the Specialty Population 204 115 Shields Health Solutions

Addressing Total Cost of Care Across the Specialty Population

This white paper describes the impact of health system specialty pharmacy utilizing an integrated care model on clinical outcomes and total cost of care.  

How Specialty Pharmacy Can Drive Better Outcomes in Diabetes 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Diabetes

This white paper explores the benefits of applying a high-touch specialty pharmacy care model, such as the Shields Diabetes Care Program, in reducing HbA1c levels and providing other clinical and…

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis

This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.…

How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosis 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosis

This white paper explores how a high-touch IDN (Integrated Delivery Network) specialty pharmacy model can help MS patients overcome barriers to medication access and achievement of therapy goals, including limited…

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients 204 115 Shields Health Solutions

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients
Drug manufacturers, payers and high-performing health system specialty pharmacies can leverage the size, scope and scale of a partner like Excelera to create efficiencies and improve the care of complex patients. Among the topics in this white paper:
  • 1
  • 2